
51 - 200 employés
Fondée en 2003
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. est une entreprise biopharmaceutique spécialisée en oncologie, concentrée sur la découverte, le développement et la commercialisation de thérapies médicinales innovantes visant à améliorer la qualité de vie des patients en oncologie. L'entreprise s'engage particulièrement à répondre aux besoins médicaux non satisfaits grâce à sa principale thérapie expérimentale, l'ivonescimab, un nouvel anticorps bispécifique conçu pour cibler à la fois PD-1 et VEGF. Les initiatives de Summit comprennent des essais cliniques de Phase III en cours pour évaluer l'efficacité de l'ivonescimab dans le traitement du cancer du poumon non à petites cellules, soulignant leur dévouement aux soins centrés sur le patient et aux avancées technologiques dans le domaine de l'oncologie.
🕒 il y a 2 mois
🇺🇸 États-Unis – Télétravail
💵 $190 000 - $237 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
👻 Score fantôme 24%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Summit Therapeutics, Inc., pas via un site d'emploi
Repérée par Remote Rocketship il y a 2 mois
Toujours ouverte sur le site de Summit Therapeutics, Inc.. Vérifiée il y a 8 heures.

51 - 200 employés
Fondée en 2003
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. est une entreprise biopharmaceutique spécialisée en oncologie, concentrée sur la découverte, le développement et la commercialisation de thérapies médicinales innovantes visant à améliorer la qualité de vie des patients en oncologie. L'entreprise s'engage particulièrement à répondre aux besoins médicaux non satisfaits grâce à sa principale thérapie expérimentale, l'ivonescimab, un nouvel anticorps bispécifique conçu pour cibler à la fois PD-1 et VEGF. Les initiatives de Summit comprennent des essais cliniques de Phase III en cours pour évaluer l'efficacité de l'ivonescimab dans le traitement du cancer du poumon non à petites cellules, soulignant leur dévouement aux soins centrés sur le patient et aux avancées technologiques dans le domaine de l'oncologie.
• Interface with US population-based decision makers, including payers, health systems, clinical pathway organizations, P&T committees, and policy makers • Educate key stakeholders on the clinical, economic, and humanistic impact of ivonescimab • Inform formulary access, pathway/guideline decisions, and improve cancer patient outcomes • Provide objective, scientifically sound medical information using economic models, outcomes tools, educational programs, and collaborations • Partner compliantly with the commercial market access field team to facilitate access to ivonescimab • Independently cultivate and manage relationships with population-based decision makers • Collaborate with HEOR and market access teams on scientific engagement strategy • Provide clinical and healthcare economic information to payers and formulary decision-makers • Communicate clinical and economic information related to ivonescimab proactively and reactively • Capture and communicate stakeholder insights, evidence gaps, and collaboration opportunities internally • Contribute to content strategy development and execute aligned field tactics • Support inclusion of ivonescimab in clinical/payer pathways and treatment order sets while optimizing budget assessments • Collaborate with medical affairs, HEOR, market access, and other colleagues on account engagement plans • Present clinical, humanistic, and economic evidence and value propositions to payer audiences • Monitor market and payer needs and provide actionable recommendations for medical and market access strategy • Perform other assigned duties
• MD, PharmD, or PhD in Health Services Research, Health Economics, or related field • Minimum of 12+ years relevant experience in the healthcare industry • Minimum of 5+ years direct experience in pharmaceutical, managed care, or consulting industries • Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC) • Previous experience in a field-based role • Strong understanding of the US healthcare system, market access landscape, and value-based decision makers • Experience analyzing healthcare data and utilizing real-world evidence (RWE) is a plus • Strong analytical capabilities • Excellent communication skills, including ability to communicate large amounts of scientific information clearly, concisely, and memorably • Ability to work collaboratively across diverse teams and manage multiple stakeholders • Ability to influence and collaborate to make a business impact • Ability to be proactive, enthusiastic, and goal oriented • Willingness to travel up to approximately 75% of the time, including overnight travel for internal and external meetings
• Bonus may be included in the total compensation package • Stock may be included in the total compensation package • Benefits may be included in the total compensation package • Other applicable variable compensation may be included • Equal opportunity employer committed to a diverse environment
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 2 mois
IQVIA executive leading strategic clinical partnerships for mid-sized pharma customers. Driving global delivery, governance, financial performance, and customer growth across healthcare services.
🇺🇸 États-Unis – Télétravail
💵 $165 400 - $460 800 / an
💰 €1 000 000 000 Post-IPO Debt en 2023-05
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Strategic services director leading North American Rail Solutions’ rail operations, growth strategies, compliance, and profitability. Managing teams, processes, customer relationships, and performance improvement.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Director leading U.S. gross-to-net forecasting, pricing strategy, and policy analytics for Otsuka’s pharmaceutical portfolio. Partnering with Finance, Market Access, Policy, and Global teams.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Creative Technology Director leading software and physical innovation projects at Deeplocal, an innovation studio creating brand experiences. Owning technical strategy, development, prototyping, and multidisciplinary project delivery.
🇺🇸 États-Unis – Télétravail
💵 $145 000 - $190 000 / an
💰 €175 000 Convertible Note - deeplocal en 2010-07
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Scientific Director overseeing evidence-based oncology medical communications for pharmaceutical, biotech, and device clients. Leading scientific content strategy, development, and account execution.
🗣️🇺🇸🇬🇧 Anglais requis